Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT06247462Phase 1Completed
Phase 1, randomised, double-blind trial of ibuprofen (2 arms), sponsored by The University of New Mexico. Primary endpoints: Urinary IGFBP7xTIMP2, Urinary NGAL and 1 more. Started Jun 2023; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT06247462.